GalNAc-conjugated TGF-β1 siRNA or LNPs containing TGF-β1 siRNA could be potential strategies to reduce the overexpressed hepatic TGF-β1 in obesity and diabetes and to treat T2D in combination with metformin. This evidence concerns the gene TGFB1 and obesity disorder.